Anterior Cruciate Ligament Reconstruction With Quadriceps Tendon Bone Autograft

January 9, 2023 updated by: Konrad Malinowski MD, Artromedical Konrad Malinowski Clinic

Anterior cruciate ligament injuries are one of the most common sports knee injuries. Their effect on the knee joint can be detrimental with patients experiencing instability and progressive damage of the intraarticular structures. Therefore, anterior cruciate ligament reconstruction (ACLR) is often indicated. Multiple graft option exist, including autograft, allograft and xenograft tissues, with autografts being considered as a first-choice source of reconstructed ligament in most cases. Two most common harvested autografts are hamstring tendons (semitendinosus or semitendinosus and gracilis tendons; ST or STG) and patellar tendon with two bone blocks (bone - patellar tendon - bone; BPTB). However, in the recent literature there is an increasing trend towards use of quadriceps tendon autograft (QT). Multiple techniques of harvesting this graft were described, including both partial and complete thickness of the tendon. Another issue is whether bone block from the upper pole of the patella is harvested along with the soft tissues (quadriceps tendon bone graft, QTB).

The aim of this study is to add to the body of knowledge concerning full-thickness quadriceps tendon-bone autograft (QTB) used in ACLR. The primary outcome consists of The International Knee Documentation Committee Questionnaire (IKDC), the Knee injury and Osteoarthritis Outcome Score (KOOS) and retear rate.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Konrad Malinowski, MD PhD
  • Phone Number: +48 509812212
  • Email: malwin8@wp.pl

Study Locations

    • Łódzkie
      • Bełchatów, Łódzkie, Poland, 97-400
        • Recruiting
        • Artromedical Orthopaedic Clinic
        • Contact:
          • Konrad Malinowski, MD PhD
          • Phone Number: +48 509 812 212
          • Email: malwin8@wp.pl

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Symptomatic knee anterior and rotatory instability after ACL injury;
  • Primary ACLR cases

Exclusion Criteria:

  • Active inflammation of the knee;
  • Revision cases;
  • Additional PLC, PCL or PFJ injuries (MCL and meniscal lesions are not exclusion criteria);
  • Fractures around the knee

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Main arm of the study
Arthroscopic anterior cruciate ligament reconstruction with quadriceps tendon bone autograft (QTB) will be performed in these patients.
Arthroscopic anterior cruciate ligament reconstruction with quadriceps tendon bone autograft (QTB) will be performed in these patients. QTB autografts will be harvested as described in the published technique: K. Malinowski, J. Paszkowski, M. Mostowy, A. Góralczyk, R.F. LaPrade, K. Hermanowicz, Quadriceps Tendon-Bone Full-Thickness Autograft: Reproducible and Easy Harvesting Technique Using Simple Surgical Tools, Arthrosc. Tech. 10 (2021) e1165-e1172. https://doi.org/10.1016/j.eats.2021.01.003. ACLR will be performed utilizing anteromedial technique with management of any accompanying intraarticular lesions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee stability
Time Frame: At the 12 month of the follow-up.
Anterior and anterolateral rotatory knee stability assessed by the means of instrumented Lachman test and pivot-shift test.
At the 12 month of the follow-up.
Knee stability
Time Frame: At the 24 month of the follow-up.
Anterior and anterolateral rotatory knee stability assessed by the means of instrumented Lachman test and pivot-shift test.
At the 24 month of the follow-up.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The functional assessment with the The International Knee Documentation Committee Questionnaire (IKDC)
Time Frame: At the 12 month of the follow-up.
Min of 0 max of 87 points, higher scores mean a better outcome
At the 12 month of the follow-up.
The functional assessment with the The International Knee Documentation Committee Questionnaire (IKDC)
Time Frame: At the 24 month of the follow-up.
Min of 0 max of 87 points, higher scores mean a better outcome
At the 24 month of the follow-up.
The functional assessment with the Knee injury and Osteoarthritis Outcome Score
Time Frame: At the 12 month of the follow-up.
Min of 0 max of 100 points, higher scores mean a better outcome
At the 12 month of the follow-up.
The functional assessment with the Knee injury and Osteoarthritis Outcome Score
Time Frame: At the 24 month of the follow-up.
Min of 0 max of 100 points, higher scores mean a better outcome
At the 24 month of the follow-up.
Retear rate
Time Frame: At the 12 month of the follow-up.
Rate of patients with retear of the reconstructed ligament
At the 12 month of the follow-up.
Retear rate
Time Frame: At the 24 month of the follow-up.
Rate of patients with retear of the reconstructed ligament
At the 24 month of the follow-up.
ROM
Time Frame: At the 12 month of the follow-up.
Knee range of motion assessed by the means of goniometer.
At the 12 month of the follow-up.
ROM
Time Frame: At the 24 month of the follow-up.
Knee range of motion assessed by the means of goniometer.
At the 24 month of the follow-up.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 28, 2020

Primary Completion (Anticipated)

December 31, 2025

Study Completion (Anticipated)

December 31, 2025

Study Registration Dates

First Submitted

January 4, 2023

First Submitted That Met QC Criteria

January 4, 2023

First Posted (Actual)

January 6, 2023

Study Record Updates

Last Update Posted (Estimate)

January 11, 2023

Last Update Submitted That Met QC Criteria

January 9, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2-pro-ar-2022

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anterior Cruciate Ligament Injuries

Clinical Trials on Arthroscopic anterior cruciate ligament reconstruction with quadriceps tendon bone autograft (QTB)

3
Subscribe